Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

RCC and BKN patients exhibited significantly lower serum levels of t-25(OH)D, 25(OH)D3, f-25(OH)D, Ca, Mg, Fe, Zn, and Ag compared to healthy controls, while C3-epi-25(OH)D3 levels were significantly elevated (P < 0.05).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Diagnostic performance of serum vitamin D metabolites and 14 inorganic elements in early prediction of kidney neoplasm

Study design awaiting verification · Frontiers in Oncology · 2026

Original publication title

Diagnostic performance of serum vitamin D metabolites and 14 inorganic elements in early prediction of kidney neoplasm

Chunmei Dai; Bin Zhang; Qiang Deng; Jiafu Feng

Copyright © 2026 Dai, Zhang, Deng and Feng.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

KN patients exhibit altered VitD metabolites and trace element profiles, with low Zn and Se potentially promoting malignancy. Free-25(OH)D, Fe, and Zn serve as protective factors, while C3-epi predisposes to disease. Combining C3-epi with f-25(OH)D and Zn, or with Fe and Zn, provides strong diagnostic accuracy for KN.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This study aimed to identify potential biomarkers by profiling serum vitamin D (VitD) metabolites and fourteen trace elements, with the goal of screening kidney neoplasm (KN) before symptom onset.

Source: Objective

Abstract: What methods does the paper describe?

The study included 57 renal cell carcinoma (RCC) patients, 43 patients with benign KN (BKN), and 50 healthy controls. Serum levels of VitD metabolites, including 25(OH)D2, 25(OH)D3, and C3-epi-25(OH)D3, were quantified using UPLC-MS/MS. The t-25(OH)D was calculated, and f-25(OH)D level was measured by ELISA. Serum concentrations of 14 inorganic elements, including calcium (Ca), magnesium (Mg), copper (Cu), iron (Fe), zinc (Zn), selenium (Se), manganese (Mn), cobalt (Co), silver (Ag), gallium (Ga), cesium (Cs), lead (Pb), cadmium (Cd), and arsenic (As), were determined by ICP-MS.

Source: Methods

Abstract: Results

RCC and BKN patients exhibited significantly lower serum levels of t-25(OH)D, 25(OH)D3, f-25(OH)D, Ca, Mg, Fe, Zn, and Ag compared to healthy controls, while C3-epi-25(OH)D3 levels were significantly elevated (P < 0.05). Additionally, RCC patients had significantly lower levels of Zn and Se, but higher levels of Ga, than BKN patients (P < 0.05). Correlation analysis revealed significant positive associations between Fe and Cs with t-25(OH)D, 25(OH)D3, C3-epi, and f-25(OH)D, as well as between Ca and t-25(OH)D and f-25(OH)D (P < 0.05).

Logistic regression analysis identified f-25(OH)D (OR = 0.762, P < 0.040), Fe (OR = 0.943, P < 0.028), and Zn (OR = 0.945, P = 0.001) as protective factors against KN, while C3-epi-25(OH)D3 (OR = 84.974, P < 0.001) was a risk factor. Receiver operating characteristic (ROC) curve analysis showed that the combination of C3-epi, f-25(OH)D, and Zn (AUC = 0.895), or C3-epi, Fe, and Zn (AUC = 0.912), did not significantly differ from the four-marker combination of C3-epi, f-25(OH)D, Fe, and Zn (AUC = 0.924).

All combined approaches outperformed individual or two-marker assays (all P < 0.05).

Source: Results

Abstract: Conclusion

KN patients exhibit altered VitD metabolites and trace element profiles, with low Zn and Se potentially promoting malignancy. Free-25(OH)D, Fe, and Zn serve as protective factors, while C3-epi predisposes to disease. Combining C3-epi with f-25(OH)D and Zn, or with Fe and Zn, provides strong diagnostic accuracy for KN.

Source: Conclusion
Authors’ abstract

Objective

This study aimed to identify potential biomarkers by profiling serum vitamin D (VitD) metabolites and fourteen trace elements, with the goal of screening kidney neoplasm (KN) before symptom onset.

Methods

The study included 57 renal cell carcinoma (RCC) patients, 43 patients with benign KN (BKN), and 50 healthy controls. Serum levels of VitD metabolites, including 25(OH)D2, 25(OH)D3, and C3-epi-25(OH)D3, were quantified using UPLC-MS/MS. The t-25(OH)D was calculated, and f-25(OH)D level was measured by ELISA. Serum concentrations of 14 inorganic elements, including calcium (Ca), magnesium (Mg), copper (Cu), iron (Fe), zinc (Zn), selenium (Se), manganese (Mn), cobalt (Co), silver (Ag), gallium (Ga), cesium (Cs), lead (Pb), cadmium (Cd), and arsenic (As), were determined by ICP-MS.

Results

RCC and BKN patients exhibited significantly lower serum levels of t-25(OH)D, 25(OH)D3, f-25(OH)D, Ca, Mg, Fe, Zn, and Ag compared to healthy controls, while C3-epi-25(OH)D3 levels were significantly elevated (P < 0.05). Additionally, RCC patients had significantly lower levels of Zn and Se, but higher levels of Ga, than BKN patients (P < 0.05). Correlation analysis revealed significant positive associations between Fe and Cs with t-25(OH)D, 25(OH)D3, C3-epi, and f-25(OH)D, as well as between Ca and t-25(OH)D and f-25(OH)D (P < 0.05).

Logistic regression analysis identified f-25(OH)D (OR = 0.762, P < 0.040), Fe (OR = 0.943, P < 0.028), and Zn (OR = 0.945, P = 0.001) as protective factors against KN, while C3-epi-25(OH)D3 (OR = 84.974, P < 0.001) was a risk factor. Receiver operating characteristic (ROC) curve analysis showed that the combination of C3-epi, f-25(OH)D, and Zn (AUC = 0.895), or C3-epi, Fe, and Zn (AUC = 0.912), did not significantly differ from the four-marker combination of C3-epi, f-25(OH)D, Fe, and Zn (AUC = 0.924).

All combined approaches outperformed individual or two-marker assays (all P < 0.05).

Conclusion

KN patients exhibit altered VitD metabolites and trace element profiles, with low Zn and Se potentially promoting malignancy. Free-25(OH)D, Fe, and Zn serve as protective factors, while C3-epi predisposes to disease. Combining C3-epi with f-25(OH)D and Zn, or with Fe and Zn, provides strong diagnostic accuracy for KN.

Publication and source details

Original title: Diagnostic performance of serum vitamin D metabolites and 14 inorganic elements in early prediction of kidney neoplasm

Chunmei Dai; Bin Zhang; Qiang Deng; Jiafu Feng

Frontiers in Oncology · 2026

* Correspondence: Jiafu Feng, jiafufeng@aliyun.com

†These authors have contributed equally to this work and share first authorship

Copyright © 2026 Dai, Zhang, Deng and Feng.2026Dai, Zhang, Deng and Fenghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This work was supported by Science and Technology Department of Sichuan Province (2021YJ0239), Medical Association of Sichuan Province(S22017) and Mianyang Central Hospital(2022YJ006).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-09T15:00:30.971541+00:00

DOI: 10.3389/fonc.2026.1884903 · PMC13437426